[1] Won EY, Cha K,Byun JS, et al. The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosisfactor superfamily[J]. J Biol Chem, 2010, 285(12): 9202-9210 [2] 刘琦,吕坤,葛晓松,等. 4-1BB配体在肿瘤细胞株上的表达及其与肿瘤细胞增殖的关系[J]. 实用临床医药杂志,2007,11(5): 49-51 [3] Scholl N, Loibl J, Kremser A, et al. The role of soluble and cellsurface expressed 4-1BB ligand in patients with malignant hemopoietic disorders[J]. Leuk Lymphoma, 2009, 50(3): 427-36 [4] Youlin K,Li Z,Xiaodong W,et al. Combination immunotherapy with 4-1BBL and CTLA-4 blockade for the treatment of prostate cancer[J]. Clin Dev Immunol, 2012, 23( 6): 439-45 [5] 段小辉, 邓锒梅, 陈雄, 等.MHCⅠ链相关分子A/B在胰腺癌组织中的表达及临床意义[J].现代生物医学进展,2009,16(2): 3038-3040 [6] Habib-Agahi M, Jaberipour M, Searle PF. 4-1BBL costimulation retrieves CD28 expression in activated T cells[J]. Cell Immunol, 2009, 256(1-2): 39-46 [7] Asai T, Choi BK, Kwon PM, et al. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice[J]. Immunology, 2007, 121(3):349-58 [8] 张敬,李贞,王婧娇,等.维甲酸相关核孤儿受体γt和4-1BB/4-1BBL在口腔扁平苔藓中的表达及意义[J].华西口腔医学杂志,2013, 31(4): 408-411 [9] 王磊.4-1BB/4-1BBL在不同胃癌细胞株中表达的研究[D].河北医科大学,2009 [10] 宋振川,李勇,刘志一,等.4-1BB/4-1BBL在胃癌组织及其外周血中的表达及临床意义[J].实用癌症杂志,2010,25(4): 337-339 [11] Kim YJ, Han MK, Broxmeyer HE. 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells[J]. Blood, 2008, 111(3): 1378-86 |